About the Academy

Myeloma is a complex and heterogeneous cancer with a myriad of co-morbidities. This, together with an increasing amount of research and the number of treatment options available, presents healthcare professionals with an enormous challenge to keep up-to-date.

This comes at a time when the NHS and Primary Care are facing unprecedented change and when healthcare professionals are finding it increasingly difficult to be released from clinical duties to access external education.

The Myeloma Academy will address these challenges and barriers head on by providing healthcare professionals with access to comprehensive, tailored learning resources in an innovative online environment.